James Cancer Hospital is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
James Cancer Hospital has participated in 7 clinical trials with 1 currently active.
Therapeutic areas: Diffuse Large B-cell Lymphoma, Anemia, Sickle Cell, Metastatic Urothelial Carcinoma.
Sponsors: Celgene Corporation, Novartis Pharmaceuticals, Acerta Pharma BV.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
James Cancer Hospital has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
James Cancer Hospital has 7 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-cell Lymphoma, Anemia, Sickle Cell, Metastatic Urothelial Carcinoma.
Yes — James Cancer Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.